Navigation
Home
About us
Products
Newsroom
Careers
Contact
Quality Policy
Bioxodes is a clinical stage biotech company specialized in the development of novel therapeutics using molecules derived from nature to prevent thrombosis and inflammatory processes.
NE
WS
Bioxodes recently published a review article highlighting the interest of
dual inhibition of factor XIIa and XIa as a therapeutic approach for safe thromboprotection
.
Mission & Vision
Our achievements
Potential therapeutic applications
Events